Inflammatory modulation effect of glycopeptide from Ganoderma capense (Lloyd) Teng

Area of Science:

• Immunology
• Pharmacology
• Natural Products

Background:

• Ganoderma capense glycopeptide (GCGP) is used for immune disorders.
• The molecular mechanisms of GCGP's immune effects are not well understood.

Purpose of the Study:

• To investigate the molecular mechanisms of GCGP's immunomodulatory effects on macrophages.
• To determine how GCGP influences inflammatory responses in immune cells.

Main Methods:

• Macrophage cell culture and stimulation with GCGP and LPS.
• Western blot analysis to assess protein expression and phosphorylation (NF-κB p65, IκB).
• NF-κB inhibitor assays and competition studies for LPS binding.

Main Results:

• GCGP maintained normal nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression in macrophages.
• GCGP's effects were linked to NF-κB signaling, involving p65 translation and IκB phosphorylation/degradation.
• GCGP inhibited the binding of lipopolysaccharide (LPS) to macrophage cells, suggesting shared receptor interactions.

Conclusions:

• GCGP exerts immunomodulatory effects on macrophages through a NF-κB-dependent pathway.
• GCGP may compete with LPS for binding to macrophage receptors.
• Understanding GCGP's mechanism provides insights into its therapeutic potential for immune disorders.